PBYI
Puma Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.55
+1.49%Forward multiples
Based on analyst estimates
- P/E forward
- 29.84x
- P/E 2026E
- 25.14x
- P/E 2027E
- 47.77x
- P/E 2028E
- 63.70x
- P/S forward
- 3.95x
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.81x
- PEG TTM
- 0.08x
- Price / book
- 3.56x
- Price / sales
- 2.13x
- Price / cash flow
- 11.98x
Enterprise value
- Enterprise value
- $403.9M
- EV / sales
- 1.75x
- EV / EBITDA
- 8.47x
- EV / EBIT
- 13.27x
- Market cap
- $493.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026